NWSA
78
-4
NUE
46
-2
ADT
35
-2
VIX
40
5
BAX
41
3
KEY
57
-3
AON
41
2
AEE
30
-13
TJX
68
3
FLR
45
2
M
56
14
CFG
50
-4
CHRW
47
-3
KSS
55
4
TDC
75
-3
COP
50
-4
CB
46
-2
WY
34
3
PRGO
44
-4
TEL
71
2
NWSA
78
-4
NUE
46
-2
ADT
35
-2
VIX
40
5
BAX
41
3
KEY
57
-3
AON
41
2
AEE
30
-13
TJX
68
3
FLR
45
2
M
56
14
CFG
50
-4
CHRW
47
-3
KSS
55
4
TDC
75
-3
COP
50
-4
CB
46
-2
WY
34
3
PRGO
44
-4
TEL
71
2
Financhill
Back

Actinium Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Sell
24

ATNM
Actinium Pharmaceuticals

Last Price:
6.97
Seasonality Move:
0.26%
Sell
46

CATX
Perspective Therapeutics

Last Price:
10.70
Seasonality Move:
-0.04%
Sell
24
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy, Sell or Hold?

  • The current Actinium Pharmaceuticals [ATNM] share price is $6.97. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $10.72. The Score for CATX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATNM Stock Price Chart

What is Actinium Pharmaceuticals's stock price today?

  • The Actinium Pharmaceuticals share price today is $6.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $10.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATNM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 36.82 Sell
Chaikin Money Flow: -26939 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.29 - 8.11) Sell
Bollinger Bands (100): (6.93 - 8.89) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 43.23 Sell
Chaikin Money Flow: 572812 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.12 - 13.08) Sell
Bollinger Bands (100): (10.11 - 15.81) Sell

ATNM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.22 Sell
20-day SMA: 7.58 Sell
50-day SMA: 8.12 Sell
200-day SMA: 6.6 Buy
8-day EMA: 7.23 Sell
20-day EMA: 7.54 Sell
50-day EMA: 7.84 Sell
200-day EMA: 7.32 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.26 Buy
20-day SMA: 11.07 Sell
50-day SMA: 14.05 Sell
200-day SMA: 8.39 Buy
8-day EMA: 10.57 Buy
20-day EMA: 11.28 Sell
50-day EMA: 12.55 Sell
200-day EMA: 9.94 Buy

Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.51 per share, an increase this year of $0.47 per share, and an increase next year of $1.18 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.

Actinium Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):